Last edition
News about "Vanderbilt University Medical Center"
Avobis Bio’s lead therapeutic, AVB-114, has received FDA’s RMAT designation for Crohn’s perianal fistulas, building on its Fast Track status to accelerate development with enhanced regulatory support and guidance.
Vanderbilt University Medical Center | 06/10/2025 | By Dineshwori | 153
Standigm and Nashville Biosciences join to revolutionize early drug discovery
Standigm and Nashville Biosciences join to revolutionize early drug discovery
Vanderbilt University Medical Center | 14/08/2023 | By Sudeep Soparkar | 749
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy